Now Available: Prosthetic Heart Valve Market - Global Forecast to 2020

Prosthetic Heart Valve Market by Type (Mechanical, Transcatheter, Tissue), and Geography (Americas, Europe, Asia-Pacific, Middle East & Africa) - Global Forecast to 2020

The global prosthetic heart valve market is USD 2.87 billion in 2014 and is expected to reach USD 4.80 billion in 2020 at a CAGR of 9.1% from 2015 to 2020.

The purpose of this report is to cover the definition, description, and forecast up to 2020 of the global prosthetic heart valve market. It involves deep dive analysis of market segmentation which comprises products and geography. The report also gives the deep insights of strategic analysis of key players for the market. In this report, the global prosthetic heart valve market has been segmented based in products, into mechanical heart valve, tissue heart valve, and transcatheter heart valve.

Full Report Details at
- http://www.fastmr.com/prod/1123563_prosthetic_heart_valve_global.aspx?afid=301

The prosthetic heart valve market has been segmented by geography, which includes major regions, such as the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into the U.S., Canada, Mexico, Brazil, Argentina, Chile, Columbia, Uruguay, and Paraguay. The Europe region has been further segmented into Germany, France, the U.K., Spain, Italy, the Netherlands, Switzerland, Belgium, Denmark, Turkey, and Russia. In Asia-Pacific, the major countries included are China, India, Japan, Australia, Republic of Korea, Singapore, Malaysia, New Zealand, Vietnam, Indonesia, Taiwan, and Thailand.

North America contributed the largest share to the global prosthetic heart valve market in 2014. The large share can be attributed to the rising aging population; increasing number of patients suffering from rheumatic heart diseases; and growing prevalence heart and vascular system conditions, such as coronary, carotid, and peripheral artery diseases and heart rhythm disturbances in the recent years.

Besides this, insurance coverage & reimbursement scenario will also influence the growth of the prosthetic heart valve market. Presently, in the U.S. Medicare (CMS) covers aortic valve replacements for the patients whose aortic heart valves are damaged. In this reimbursement, the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) made a joint decision that will permit the CMS to cover transcatheter aortic valve replacement (TAVR). Moreover, the reimbursements for medical devices including valve, stent, and pacemaker, among others are evaluated on a case-to-case basis.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- MediPoint: Prosthetic Heart Valves - Global Analysis and Market Forecasts
- MediPoint: Prosthetic Heart Valves - 5EU Analysis and Market Forecasts
- MediPoint: Prosthetic Heart Valves - APAC Analysis and Market Forecasts
- MediPoint: Prosthetic Heart Valves - South America Analysis and Market Forecasts
- MediPoint: Prosthetic Heart Valves - US Analysis and Market Forecasts